PRCT vs SGP: stock comparison and AI forecast
Procept Biorobotics Corp (PRCT) and Spyglass Pharma, Inc. (SGP) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
PRCT Procept Biorobotics Corp
- Price
- $19.44 -21.7% · 6M
- Market Cap
- $1.11B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
SGP Spyglass Pharma, Inc.
- Price
- $33.64 +37.8% · 6M
- Market Cap
- $1.13B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- PRCT and SGP have similar market capitalizations ($1.11B and $1.13B).
- Over the last six months SGP returned +37.8% and PRCT -21.7%.
- PRCT carries 0.41 times debt per unit of equity, against 0.05 times for SGP.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | PRCT | SGP |
|---|---|---|
| Market Cap | $1.11B | $1.13B |
| P/B Ratio | 3.27x | 4.84x |
| EPS | $-1.84 | – |
| Book Value/Share | $5.94 | $6.95 |
| Revenue/Share | $5.89 | – |
| FCF/Share | $-1.48 | – |
Profitability & Margins
| Metric | PRCT | SGP |
|---|---|---|
| ROE | -32.3% | – |
| ROA | -22.9% | – |
| ROIC | -27.5% | – |
| Gross Margin | 64.2% | – |
| Operating Margin | -33.9% | – |
| Net Margin | -32.5% | – |
| EBT Margin | -30.9% | – |
| Tax Rate | -0.2% | – |
Financial Health
| Metric | PRCT | SGP |
|---|---|---|
| Current Ratio | 6.55x | 25.06x |
| Quick Ratio | 5.35x | – |
| D/E Ratio | 0.41x | 0.05x |
| Financial Leverage | 1.41x | 1.05x |
| Interest Coverage | -34.7x | – |
| Working Capital | $356M | $227M |
Cash Flow
| Metric | PRCT | SGP |
|---|---|---|
| Operating Cash Flow | -$74M | – |
| Free Cash Flow | -$85M | – |
| Capital Spending | -$11M | – |
| FCF/Sales | -25.2% | – |
| CapEx/Sales | 3.1% | – |
Operational Efficiency
| Metric | PRCT | SGP |
|---|---|---|
| Asset Turnover | 0.70x | – |
| Receivables Turnover | 3.1x | – |
| Inventory Turnover | 1.6x | – |
| Fixed Assets Turnover | 10.6x | – |
| Days Sales Outstanding | 116 days | – |
| Days Inventory | 233 days | – |
| Payables Period | 46 days | – |
| Cash Conversion Cycle | 304 days | – |
Income Statement
| Metric | PRCT | SGP |
|---|---|---|
| Total Revenue | $337M | – |
| Operating Income | -$114M | – |
| Net Income | -$110M | – |
| R&D Expense | $79M | – |
| SG&A Expense | $252M | – |
| Cost of Goods Sold | $121M | – |
Dividend & Shareholder Information
| Metric | PRCT | SGP |
|---|---|---|
| Shares Outstanding | 57M | 33M |
PRCT vs SGP: stock comparison and AI forecast
Which is bigger, PRCT or SGP?
PRCT and SGP have similar market capitalizations ($1.11B and $1.13B).
Which stock performed better over the last six months, PRCT or SGP?
Over the last six months SGP returned +37.8% and PRCT -21.7%.
Which one does Intratio's AI model rank higher, PRCT or SGP?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.